SCHEMBL9018025

SCHEMBL9018025

CCCCCOC(=O)Oc1ccc(C(=O)NS(=O)(=O)c2ccccc2)cn1

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 4/20 0.53
PTGS2 P35354 2/20 0.45
PTGS1 P23219 1/20 0.44
GABRA5 P31644 1/20 0.43
EGFR P00533 3/20 0.42
KAT6A Q92794 1/20 0.41
BCL2L1 Q07817 2/20 0.40
MCL1 Q07820 2/20 0.40
ALKBH2 Q6NS38 1/20 0.40
ALKBH5 Q6P6C2 1/20 0.40
FTO Q9C0B1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9018024 0.93 P4HTM (0.56) P4HTMPTGS2PTGS1GABRA5EGFR
SCHEMBL9018013 0.88 P4HTM (0.58) P4HTMPTGS2PTGS1GABRA5EGFR
SCHEMBL9018292 0.84 HSD17B10 (0.48)
SCHEMBL7870518 0.84 P4HTM (0.64) P4HTMPTGS2PTGS1EGFRBCL2L1
SCHEMBL9018238 0.82 KMT2A (0.43) P4HTMKAT6ABCL2L1MCL1
SCHEMBL9018433 0.82 CTDSP1 (0.41)
SCHEMBL9018213 0.81 SMN1; SMN2 (0.45) P4HTMKAT6ABCL2L1MCL1
SCHEMBL9018214 0.81 P4HTM (0.55) P4HTMPTGS2PTGS1GABRA5EGFR
SCHEMBL7874636 0.81 P4HTM (0.52) P4HTMEGFRBCL2L1MCL1
SCHEMBL9018209 0.81 L3MBTL1 (0.50) P4HTMBCL2L1MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0590520-B1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments HOECHST AG (DE) 1996-06-12 EP disclosed
EP-0590520-A1 Acylsulphonamido and sulphonamidopyridine-2-carboxylic acid esters, pyridine-n-oxides thereof, a process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1994-04-06 EP disclosed